注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Sutro Biopharma, Inc是一家臨床階段的從事藥物研發和生產的公司。該公司專注於部署其集成的無細胞蛋白質合成平台XpressCF,為癌症和自身免疫性疾病創造各種蛋白質療法。該公司致力於採用強力手段設計治療方法,包括基於細胞因子的治療方法、免疫腫瘤學(I/O)藥物、抗體藥物複合物(ADC)和主要針對臨床驗證靶點的雙特異性抗體。其候選產品包括STRO-001和STRO-002。STRO-001是一種針對癌症靶點CD74的ADC,適用於多發性骨髓瘤和非霍奇金淋巴瘤(NHL)患者。STRO-002是一種針對葉酸受體(FolRa)的ADC,適用於卵巢癌和子宮內膜癌患者。通過將接頭彈頭放置在抗體內的特定位置,對STRO-001和STRO-002的設計根據治療指數進行了優化。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
William J. Newell | 64 | 2009 | CEO & Director |
Connie L. Matsui | 68 | 2019 | Independent Chair of the Board |
Joseph M. Lobacki | 64 | 2017 | Independent Director |
Lawrence Fong | - | - | Co-Chair of Clinical Advisory Board & Member of Scientific Advisory Board |
Carlos V. Paya | 64 | 2020 | Chair of the Scientific Advisory Board |
Daniel H. Petree | 67 | 2009 | Independent Director |
Heidi Hunter | 65 | 2021 | Independent Director |
Trevor J. Hallam | 64 | 2010 | Member of Scientific Advisory Board |
Michael P. Dybbs | 48 | 2018 | Independent Director |
Lainie P. Martin | - | 2020 | Member of the Clinical Advisory Board |
Ana Oaknin Benzaquen | - | 2021 | Member of the Clinical Advisory Board |
John Gordon Freund | 69 | 2014 | Independent Director |
Amrita Krishnan | - | - | Member of Clinical Advisory Board |
Robert T. Abraham | 69 | - | Member of Scientific Advisory Board |
John P. Leonard | - | - | Member of Clinical Advisory Board |
James P. Panek | 69 | 2020 | Independent Director |
Jon Marc Wigginton | 61 | 2020 | Independent Director |
Stanley R. Frankel | 63 | - | Member of Scientific Advisory Board |
R. Wendel Naumann | - | - | Member of Clinical Advisory Board |
Richard T. Penson | - | - | Member of Clinical Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核